Phase II Study of Activated Charcoal to Prevent Irinotecan-Induced Diarrhea
Journal of Clinical Oncology
Vol 22, No 21 (November 1), 2004: pp. 4410-4417
Michael Michael, MaryAnne Brittain, Jane Nagai, Ronald Feld, David Hedley, Amit Oza, Lillian Siu, Malcolm J. Moore
DOI: 10.1200/JCO.2004.11.125
Go to journal article.
Journal Article: Preventing Irinotecan-Induced Diarrhea
Cancer Research - November 2004
From Donna Myers, former About.com Guide
Updated: August 7, 2005
About.com Health's Disease and Condition content is reviewed by the Medical Review Board
Related Articles
- Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients ...
- Phase II Study of Neoadjuvant 5-FU + Leucovorin + CPT-11 in Patients with R...
- Phase I/II Study of First-Line Irinotecan Combined with 5-Fluorouracil and ...
- Phase II Study of Capecitabine in Patients With Fluorouracil-Resistant Meta...
- Curing Alzheimer's: A Cautionary Tale - Alzheimer's Disease
Top Related Searches journal of clinical oncology david hedley ronald feld activated charcoal irinotecan oza
Explore Colon Cancer
- About.com
- Health
- Colon Cancer
- Basics
- Research Articles
- Journal Article Abstracts
- Journal Articles from 2004
- Phase II Study of Activated Charcoal to Prevent Irinotecan-Induced Diarrhea
Also from About.com:
©2013 About.com. All rights reserved.
